This episode is brought to you by Semafor Healthcare.
Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.
Last week, a new rule from the Centers for Medicare & Medicaid Services was finalized, establishing the framework for the Medicare Drug Price Negotiation Program in 2029.
In this emergency podcast episode, Rachel Sachs of Washington University in St. Louis breaks down the new framework, explains how the Medicare drug price negotiation process continues to evolve, and highlights the key questions stakeholders will be watching as implementation moves forward.
The conversation also examines the broader trajectory of federal drug pricing policy in the wake of the Trump administration's Great Healthcare Plan.
Podden och tillhörande omslagsbild på den här sidan tillhör
Health Affairs. Innehållet i podden är skapat av Health Affairs och inte av,
eller tillsammans med, Poddtoppen.
